Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New device eases insulin injection:

This article was originally published in Clinica

Executive Summary

Danish medical equipment manufacturers Novo Nordisk have launched the "InnoLet", an insulin injection device designed to make the delivery of insulin into the body easier for elderly, or partially-sighted people. The device, developed together with the Danish Institute for the Blind and Partially Sighted (DIBPS) and the Spanish National Organisation for the Blind (ONCE), allows for a one-handed delivery of the insulin dose. Roger Lassing of Novo Nordisk described the device as egg-timer shaped with large printed numbers. The design was a result of comprehensive market research which prompted the company to create a large-scale device in order to compensate for failing manual dexterity in the elderly.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT074936

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel